KCT0001963已完成未知
Immunogenicity study of 23-valent pneumococcal polysaccharide vaccine in korean elderly people
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 65(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •Eligible individuals were ambulatory adults aged =65 yearswho never received the pneumococcal vaccine and in whom underlying chronic illnesses such as hypertension and diabetes mellituswere stable.
排除标准
- •Exclusion criteria were immune compromising conditions such as HIV infection, leukemia, lymphoma, Hodgkin’sdisease, multiple myeloma, generalized malignancy, chronic renalfailure or nephrotic syndromes, congenital or acquired immunode-ficiencies, diseases requiring treatment using immunosuppressivedrugs, including long-term systemic corticosteroids or radiationtherapy, solid organ transplantation, functional or anatomic asplenia, cerebrospinal fluid leaks or cochlear implants, a history of hypersensitivity to vaccine or invasive pneumococcal diseases, any coagulation disorder, and a history of antibiotic use within one week.
研究者
相似试验
已完成
不适用
Study of the immunogenicity of 13-valent pneumococcal conjugate vaccine in high-risk patients who were outside recommended ages for routine vaccinatiohematological malignancies and post hematopoietic stem cell transplantationsJPRN-UMIN000038760Chiba university42
招募中
2 期
Immunogenicity and Safety of a 13-valent pneumococcal conjugate vaccine in paediatric oncology patientspaediatric malignancyCancer - Children's - BrainCancer - Children's - Leukaemia & LymphomaCancer - Children's - OtherACTRN12613000264785Te-Yu Hung100
尚未招募
4 期
Immunogenicity and Safety of Pneumococcal 13-valent Conjugate Vaccine between Weuphoria and Prevnar 13 in Thai Older PeopleHealthy participants with no health conditions or stable chronic diseases.-TCTR20230923001ational Vaccine Institute (NVI)408
进行中（未招募）
不适用
Evaluation of immunogenicity of 7-valent Pneumococcal Conjugate Vaccine (Prevenar) and Hexavalent DtPa-HBV-IPV-Hib (InfaNrix Hexa), co-administered at the same time, versus Hexavalent vaccine, used in primary immunization schedule - NDHealthy childrenMedDRA version: 6.1Level: PTClassification code 10062163EUCTR2007-003692-39-ITAZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO GENOVA
已完成
1 期
Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native EldersPneumococcal InfectionsNCT00153543Centers for Disease Control and Prevention86